1. Home
  2. XBIT vs LFVN Comparison

XBIT vs LFVN Comparison

Compare XBIT & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.20

Market Cap

70.1M

Sector

Health Care

ML Signal

HOLD

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.20

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
LFVN
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.1M
78.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XBIT
LFVN
Price
$2.20
$6.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
45.0K
47.1K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
3.56%
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$203,204,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$15.63
Revenue Growth
N/A
1.86
52 Week Low
$2.09
$3.90
52 Week High
$3.44
$12.10

Technical Indicators

Market Signals
Indicator
XBIT
LFVN
Relative Strength Index (RSI) 40.99 40.47
Support Level $2.21 $6.17
Resistance Level $2.46 $6.97
Average True Range (ATR) 0.07 0.32
MACD -0.01 -0.06
Stochastic Oscillator 11.76 32.70

Price Performance

Historical Comparison
XBIT
LFVN

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium, and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

Share on Social Networks: